AstraZeneca: Respiration Disorders trials

The registry lists 15 Respiration Disorders studies with AstraZeneca as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 1 3Phase 2 8Phase 4 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)CompletedNCT01443845Phase 4Results posted
• Evaluation of the Effect of AZD5069 in Patients With BronchiectasisCompletedNCT01255592Phase 2Results posted
• A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01233232Phase 2Results posted
• AZD2423 Safety and Tolerability Study in Patients With Moderate and Severe Chronic Obstructive Pulmonary Disease(COPD)CompletedNCT01215279Phase 2Results posted
• Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01153321Phase 2Results posted
• Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01054170Phase 2Results posted
• Efficacy and Safety of Twice Daily 60mg AZD9668 in COPD for 12 Weeks in Patients on Background Budesonide/FormoterolCompletedNCT01023516Phase 2Results posted
• A Dose Range Finding Study to Evaluate the Efficacy and Safety of AZD9668 Administered Orally at Three Dose Levels to Patients With Chronic Obstructive Pulmonary Disease (COPD) on Treatment With TiotropiumCompletedNCT00949975Phase 2Results posted
• A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00703391Phase 2Results posted
• A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD)CompletedNCT02300090
• Observational Study to Evaluate the Correctness of the Use of Inhaler Device in Patients With Asthma or Chronic ObstructCompletedNCT01426893
• AZD2115 Single Ascending Dose StudyCompletedNCT01283984Phase 1
• To Evaluate the Effect of AZD3199 on the Electrical Activity in the HeartCompletedNCT01222442Phase 1
• A Study to Assess Safety, Tolerability and Pharmacokinetics of of AZD6553 in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT01068184Phase 1
• Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High RiskCompletedNCT00192439